AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇹🇳
PERINDOPRIL ARGININE+ INDAPAMIDE+ AMLODIPINE in Tunisia
4 products registered with DPM — 0 active, 4 expired
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| TRIPLIXAM Comprimé pelliculé / 5mg/1.25mg/5mg | 9254201 | TERIAK | expired | 26 Mar 2021 |
| TRIPLIXAM Comprimé pelliculé / 10mg/2.5mg/5mg | 9254203 | TERIAK | expired | 26 Mar 2021 |
| TRIPLIXAM Comprimé pelliculé / 10mg/2.5mg/10 mg | 9254204 | TERIAK | expired | 26 Mar 2021 |
| TRIPLIXAM Comprimé pelliculé / 5mg/1.25mg/10mg | 9254202 | TERIAK | expired | 26 Mar 2021 |
PERINDOPRIL ARGININE+ INDAPAMIDE+ AMLODIPINE — DPM Registration Details
DPM (Tunisia) has 4 registered products containing PERINDOPRIL ARGININE+ INDAPAMIDE+ AMLODIPINE, of which 0 are currently active. Data is sourced directly from the official DPM drug register and refreshed daily.
Track PERINDOPRIL ARGININE+ INDAPAMIDE+ AMLODIPINE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.